Karaciğer Kistlerinin Değerlendirilmesi
Özet
Karaciğerin kistik lezyonları, etiyoloji, klinik görünüm ve tedavi yaklaşımları açısından oldukça heterojen ve çoğunlukla rastlantısal olarak saptanan selim seyirli bir hastalık grubudur. En sık görülen benign oluşum, genellikle asemptomatik olan ve ultrasonografi ile maliyet-etkin şekilde teşhis edilebilen basit kistlerdir. Ancak, malign transformasyon riski taşıyan biliyer kistadenom ve kistadenokarsinom gibi neoplastik yapıların yanı sıra, paraziter kökenli kistik ve alveoler ekinokokkus olgularının doğru ayırt edilmesi kritik önem taşır. Ayrıca, intrahepatik safra kanallarının segmental kistik dilatasyonu ile karakterize Caroli hastalığı ve genetik geçişli polikistik karaciğer hastalığı da bu spektrumda yer alır. Tedavi yaklaşımları lezyonun türüne ve semptomlara göre değişiklik göstermekte; basit kistlerde bekle-gör politikası, skleroterapi veya laparoskopik fenestrasyon tercih edilirken, neoplastik ve şüpheli lezyonlarda altın standart cerrahi rezeksiyondur.
Cystic lesions of the liver represent a highly heterogeneous group of diseases in terms of etiology, clinical manifestation, and treatment, which are mostly diagnosed incidentally and follow a benign course. Simple cysts are the most common benign lesions; they are generally asymptomatic and accurately diagnosed using cost-effective ultrasonography. However, distinguishing simple cysts from neoplastic lesions with malignant potential, such as biliary cystadenoma and cystadenocarcinoma, as well as parasitic infections like cystic and alveolar echinococcosis, is of paramount importance. This clinical spectrum also encompasses Caroli’s disease, characterized by segmental cystic dilatation of intrahepatic bile ducts, and genetically transmitted polycystic liver disease. Management strategies vary significantly based on the specific type of lesion and symptoms, ranging from observation, sclerotherapy, or laparoscopic fenestration for simple cysts, to radical surgical resection as the gold standard for neoplastic and suspicious masses.
Referanslar
Cheng, EY. (2016). Schwartz Cerrahinin İlkeleri. ( M. Mahir Özmen, Çev. Ed.). Ankara: Güneş Tıp Kitabevleri
Doherty GM, Way LW. Liver & Portal Venous System. In: Way LW, Doherty GM (Eds). Current Surgical Diagnosis & Treatment, 11th edition, Lange Medical Books/McGraw-Hill medical Publishing Division, Philadelphia, 2003; p. 565-594.
Lantiga MA, Gevers TJG, Drenth JPH. Evaluation of hepatic cytic lesions. World J Gastroenterol 2013; 19: 3543-3554.
Kapan, M. Kapan, S. Karaciğerin Parazitik Olmayan Kistlerine Yaklaşım. Bakırköy Tıp Dergisi 2013;9:145-151. DOI: 10.5350/BTDMJB201309401
Läuffer JM, Baer HU, Maurer CA, Stoupis C, Zimmerman A, Büchler MW. Biliary cystadenocarcinoma of the liver: the need for complete resection. Eur J Cancer 1998; 34: 1845-1851 [PMID: 10023304 DOI: 10.1016/S0959-8049(98)00166-X]
Macedo FI. Current management of noninfectious hepatic cystic lesions: A review of the literature. World J Gastroenterol 2013; 27: 462-469.
Nagorney DM. Surgical management of cystic disease of the liver. In: Blumgart LH, Fong Y (Eds) Surgery of the Liver and Biliary Tract, 3rd edition, WB Saunders, 2000: p. 1261-1274.
Bahirwani R, Reddy KR. Review article: the evaluation of solitary liver masses. Aliment Pharmacol Ther 2008; 28: 953-965 [PMID: 18643922 DOI: 10.1111/j.1365-2036.2008.03805.x]
Waanders E, van Keimpema L, Brouwer JT, van Oijen MG, Aerts R, Sweep FC, Nevens F, Drenth JP. Carbohydrate antigen 19-9 is extremely elevated in polycystic liver disease. Liver Int 2009; 29: 1389-1395 [PMID: 19515221 DOI: 10.1111/ j.1478-3231.2009.02055.x]
Yan-Hong F, Lin-Xue Q, Hai-Ma G, Qıng Z, Yu G, Xiangdong H. Sclerotherapy of simple hepatic cysts by repeated aspiration and alcohol instillation. Turkish J Gastroenterol 2012; 23: 359-365.
Ardito F, Bianco G, Vellone M, et al. Long-term outcome after laparoscopic fenestration of simple liver cysts. Surg Endosc DOI 10.1007/s00464-013-3104-3, Published online 13/8/2013.
Hernandez Bartolome MA, Fuerte Ruiz S, Manzanedo Romero I, Ramos Lojo B, Rodriguez Prieto I, Gimenez Alvira L, Granados Carreño R, Limones Esteban M. Biliary cystadenoma. World J Gastroenterol 2009; 15: 3573-3575 [PMID: 19630118 DOI: 10.3748/wjg.15.3573]
Ahanatha Pillai S, Velayutham V, Perumal S, Ulagendra Perumal S, Lakshmanan A, Ramaswami S, Ramasamy R, Sathyanesan J, Palaniappan R, Rajagopal S. Biliary cystadenomas: a case for complete resection. HPB Surg 2012; 2012: 501705 [PMID: 22778493 DOI: 10.1155/2012/501705]
Baş B, Çekin AH, Karaciğer kistik hastalıklarına yaklaşım. Güncel Gastroenteroloji. Mart 2020
Li X, Zhang JL, Wang YH, et al. Hepatobiliary cystadenoma and cystadenocarcinoma: a single center experience. Tumori 2013; 99: 261-265.
Soares KC, Arnaoutakis DJ, Kamel I, et al. Cystic neoplasms of the liver: biliary cystadenoma and cystadenocarcinoma. Am Coll Surg ISSN 1072-7515/13/$36.00 published online, 2013.
Zhang DY, Fei ZJI, Shen XZ, Lıu HY, Pan BJ, Dong L. Caroli’s disease: A report of 14 patients and review of the literature. J Dig Dis 2012; 13: 491-495.
Mabrut JY, Kianmanesh R, Nuzzo G, et al. Surgical Management of Congenital Intrahepatic Bile Duct Dilatation, Caroli’s Disease and Syndrome. Long-term Results of the French Association of Surgery Multicenter Study. Ann Surg 2013; 258: 713-721.
Levy AD, Rohrmann CA, Murakata LA, Lonergan GJ. Caroli’s disease: radiologic spectrum with pathologic correlation. AJR Am J Roentgenol 2002; 179: 1053-1057 [PMID: 12239064 DOI: 10.2214/ajr.179.4.1791053]
Yılmaz B, Arslan M, Balamtekin N. Caroli Disease: Case report. International Journal of Scientific and Technological Research Special Issue of Health Sciences, Vol.6, No.3, 2020. DOI: 10.7176/JSTR/6-03-03
Yılmaz S, Kırımlıoğlu H, Kırımlıoğlu V, Işık B, Çoban S, Yıldırım B, Ara C, Söğütlü G, Yılmaz M. Partial hepatectomy is curative for the localized type of Caroli’s disease: a case report and review of the literature. Surgeon 2006; 4: 101-105 [PMID: 16623167 DOI: 10.1016/S1479-666X(06)80039-9]
Drenth JP, Martina JA, Te Morsche RH, Jansen JB, Bonifacino JS. Molecular characterization of hepatocystin, the protein that is defective in autosomal dominant polycystic liver disease. Gastroenterol 2004; 126: 1819-1827 [PMID 15188177 DOI: 10.1053/j.gastro.2004.02.023]
Van Keimpema L, De Koning DB, Van Hoek B, et al. Patients with isolated polycystic liver disease referred to liver centres: clinical characterization of 137 cases. Liver Int 2011;31:92-8
Macutkiewicz C, Plastow R, Chrispijn M, et al. Complications arising in simple and polycystic liver cysts. World J Gastroenterol 2012; 4: 406-411.
Nunnari G, Pinzone MR, Gruttadauria S, et al. Hepatic echinococcosis: clinical and therapeutic aspects. World J Gastroenterol 2012;18:1448- 58.
Grosso G, Gruttadauria S, Biondi A, Marventano S, Mistretta A. Worldwide epidemiology of liver hydatidosis including the Mediterranean area. World J Gastroenterol 2012;18:1425-37.
Mandal S, Mandal MD. Human cystic echinococcosis: epidemiologic, zoonotic, clinical, diagnostic and therapeutic aspects. Asian Pac J Trop Med 2012;5:253-60.
Kern P. Clinical features and treatment of alveolar echinococcosis. Curr Opin Infect Dis 2010;23:505-12.
Brunetti E, Kern P, Vuitton DA; Writing Panel for the WHO-IWGE. Expert consensus for the diagnosis and treatment of cystic and alveolar echinococcosis in humans. Acta Trop. 2010;114:1-16.
